Aspira Women’s Health Inc.: basic earnings per share

What this measure means

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Exact concept: us-gaap:EarningsPerShareBasic. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2012-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.

Reading these values

This selected numerical history matches Diluted earnings per share for the same reporting intervals and original units. The accounting definitions remain distinct. Equal values do not establish that the concepts are interchangeable or explain why they match; filing dates and accessions may differ. Compare the definitions and source filings before combining them.

Context from the filing

For Aspira Women's Health in 2024 and 2025, participating warrant holders have no contractual obligation to share losses, so losses are allocated entirely to common stockholders. The filing excludes anti-dilutive common equivalents and reports identical basic and diluted loss per share. Dollar losses are displayed in thousands; share counts and per-share amounts are unscaled. These reported historical values are retained. Read the source filing.

Selected filing history

Related financial histories

• Aspira Women’s Health Inc.: total assets
• Aspira Women’s Health Inc.: total liabilities
• Aspira Women’s Health Inc.: stockholders equity
• Aspira Women’s Health Inc.: cash and cash equivalents
• Aspira Women’s Health Inc.: net income or loss
• Aspira Women’s Health Inc.: operating cash flow
• Aspira Women’s Health Inc.: capital expenditure payments
• Aspira Women’s Health Inc.: revenue
• Aspira Women’s Health Inc.: contract revenue excluding tax
• Aspira Women’s Health Inc.: financing cash flow
• Aspira Women’s Health Inc.: investing cash flow
• Aspira Women’s Health Inc.: retained earnings or deficit
• Aspira Women’s Health Inc.: basic weighted-average shares
• Aspira Women’s Health Inc.: diluted weighted-average shares
• Aspira Women’s Health Inc.: diluted earnings per share
• Aspira Women’s Health Inc.: net property, plant and equipment
• Aspira Women’s Health Inc.: share-based compensation expense
• Aspira Women’s Health Inc.: operating income or loss
• Aspira Women’s Health Inc.: current assets
• Aspira Women’s Health Inc.: interest expense
• Aspira Women’s Health Inc.: current liabilities
• Aspira Women’s Health Inc.: current accounts payable
• Aspira Women’s Health Inc.: net current accounts receivable
• Aspira Women’s Health Inc.: operating expenses
• Aspira Women’s Health Inc.: net inventory
• Aspira Women’s Health Inc.: gross profit
• Aspira Women’s Health Inc.: research and development expense

Inspect the source

Entity

Aspira Women’s Health Inc. / CIK 0000926617

Captured

2026-09-20T05:08:46.532Z

SEC response SHA-256

4aa7c80ecb27ea79b0d5b639913356a502fdcf1c28d7b8cfb49990c080ce3770

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000926617.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))